TCI Wealth Advisors, Inc. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$0100.0%0.00%
Q4 2019$0100.0%0.00%
Q3 2019$0100.0%0.00%
Q2 2019$0100.0%0.00%
Q1 2019$0100.0%0.00%
Q4 2018$0100.0%0.00%
Q3 2018$0100.0%0.00%
Q2 2018$0100.0%0.00%
Q1 2018$0100.0%0.00%
Q4 2017$0100.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$6,545,0003.19%
COURAGE CAPITAL MANAGEMENT LLC 200,000$1,098,0000.74%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 174,512$958,0000.06%
Family Management Corp 14,000$77,0000.05%
EAM Investors, LLC 62,752$345,0000.05%
FNY Managed Accounts LLC 4,400$24,0000.03%
ACADIAN ASSET MANAGEMENT LLC 1,090,397$5,988,0000.03%
REILLY FINANCIAL ADVISORS, LLC 22,011$121,0000.02%
Alambic Investment Management, L.P. 28,500$156,0000.02%
Caprock Group, LLC 14,085$77,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders